Martijn H, Schraffordt Koops H, Milton G W, Nap M, Oosterhuis J W, Shaw H M, Oldhoff J
Cancer. 1986 May 15;57(10):1923-30. doi: 10.1002/1097-0142(19860515)57:10<1923::aid-cncr2820571006>3.0.co;2-e.
A comparative retrospective study of patients with primary malignant melanomas of the extremities, Clark level IV/V and tumor thickness greater than or equal to 1.5 mm, was performed in Sydney (Australia) and Groningen (The Netherlands). The efficacy of wide local excision combined with adjuvant regional perfusion (Groningen) was compared with that of wide surgical excision only (Sydney). Patients were classified by sex and tumor location. There were only sufficient numbers of female patients with a tumor of the lower extremity available for this comparative study. All patients were stage I and none received prophylactic lymph node dissection. Age, tumor location, tumor thickness, depth of infiltration and ulceration were taken into account and the factors studied within this group were 10-year disease-free rate, 10-year survival rate, and local and regional recurrences. Women with a melanoma of the leg (excluding the foot) who had been treated by excision and adjuvant regional perfusion, had a significantly better 10-year disease-free rate (P less than 0.0005), a significantly higher 10-year survival rate (0.010 less than P less than 0.025) and significantly fewer local/regional recurrences (P less than 0.0005) than women treated by wide local excision only. For tumors of the foot, however, no significant differences in 10-year disease-free rate, 10-year survival rate or local/regional recurrences were observed after perfusion.
在悉尼(澳大利亚)和格罗宁根(荷兰)对四肢原发性恶性黑色素瘤患者进行了一项比较性回顾性研究,这些患者的克拉克分级为IV/V级,肿瘤厚度大于或等于1.5毫米。将广泛局部切除联合辅助区域灌注(格罗宁根)的疗效与仅进行广泛手术切除(悉尼)的疗效进行了比较。患者按性别和肿瘤位置进行分类。只有足够数量的下肢肿瘤女性患者可用于这项比较研究。所有患者均为I期,且均未接受预防性淋巴结清扫。考虑了年龄、肿瘤位置、肿瘤厚度、浸润深度和溃疡情况,该组研究的因素包括10年无病生存率、10年生存率以及局部和区域复发情况。接受切除和辅助区域灌注治疗的腿部(不包括足部)黑色素瘤女性患者,其10年无病生存率显著更高(P<0.0005),10年生存率显著更高(0.010<P<0.025),局部/区域复发显著更少(P<0.0005),而仅接受广泛局部切除治疗的女性患者则不然。然而,对于足部肿瘤,灌注后10年无病生存率、10年生存率或局部/区域复发情况未观察到显著差异。